Showing results (291-300 of 3,163) with videos related to
Sort By:
Pageof 317
Translational Oncology|March 26, 2018
The Modifying Effect of a Functional Variant at the miRNA Binding Site in E2F1 Gene on Recurrence of Oropharyngeal Cancer Patients with Definitive RadiotherapyHua Zhang, Erich Sturgis, Lijun Zhu, et al.Translational Oncology|November 18, 2017
Genetic and Clinical Characteristics of Phyllodes Tumors of the BreastJi-Yeon Kim, Jong Han Yu, Seok Jin Nam, et al.Translational Oncology|May 26, 2022
Suppression of FAM83D Inhibits Glioma Proliferation, Invasion and Migration by Regulating the AKT/mTOR Signaling PathwayXia Li, Cui Sun, Jing Chen, et al.Translational Oncology|June 30, 2021
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinibRuofei Yu, Hua Bai, Tangai Li, et al.Translational Oncology|June 2, 2022
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutationAsim Joshi, Ashwin Butle, Supriya Hait, et al.Translational Oncology|January 8, 2018
IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB SignalingYuan-Hua Xu, Zheng-Li Li, Sheng-Feng QiuTranslational Oncology|December 7, 2018
Associations Between PET Parameters and Expression of Ki-67 in Breast CancerAlexey Surov, Hans Jonas Meyer, Andreas WienkeTranslational Oncology|December 18, 2018
Subcutaneous Inoculation of 3D Pancreatic Cancer Spheroids Results in Development of Reproducible Stroma-Rich TumorsMikhail Durymanov, Christian Kroll, Anastasia Permyakova, et al.Translational Oncology|December 19, 2018
Up-Regulated FGFR1 Expression as a Mediator of Intrinsic TKI Resistance in EGFR-Mutated NSCLCKristine Raaby Gammelgaard, Johan Vad-Nielsen, Michelle Simone Clement, et al.Translational Oncology|December 22, 2018
Quantitative Chemotherapeutic Profiling of Gynecologic Cancer Cell Lines Using Approved Drugs and Bioactive CompoundsKirill Gorshkov, Ni Sima, Wei Sun, et al.Pageof 317